P&G Acquires Thorne for $3.8 Billion, Expanding Wellness Portfolio

Procter & Gamble (P&G) has made a significant move into the wellness space by acquiring Thorne, a company that specializes in science-based supplements, for $3.8 billion.

The deal marks P&G's continued expansion of its Health Care portfolio, which has evolved from a traditional consumer healthcare business to a broader health and wellness platform.

Thorne has built a reputation over four decades on scientific rigour, product quality, and a strong relationship with the healthcare practitioner channel. Its products are recommended by tens of thousands of healthcare practitioners and used by more than seven million consumers.

The acquisition reflects a rapid rise in Thorne's value, from a public listing at $525 million in 2021 to over $3.8 billion today.